Acute Myelomonoblastic Leukemia (My1/De): a Preclinical Rat Model

Arató, Viktória Zsófia and Képes, Zita and Péli-Szabó, Judit and Farkasinszky, Gergely and Sass, Tamás and Dénes, Noémi and Kis, Adrienn and Opposits, Gábor and Jószai, István and Kálmán, Ferenc Krisztián and Hajdu, István and Trencsényi, György and Kertész, István (2024) Acute Myelomonoblastic Leukemia (My1/De): a Preclinical Rat Model. IN VIVO, 38 (3). pp. 1064-1073. ISSN 0258-851X

Preview

Text in_vivo-38-1064.pdf - Published Version Download (3MB) | Preview

Abstract

Background/Aim: Since acute myeloid leukemias still represent the most aggressive type of adult acute leukemias, the profound understanding of disease pathology is of paramount importance for diagnostic and therapeutic purposes. Hence, this study aimed to explore the real-time disease fate with the establishment of an experimental myelomonoblastic leukemia (My1/De) rat model using preclinical positron emission tomography (PET) and whole-body autoradiography. Materials and Methods: In vitro [18F]F-FDG uptake studies were performed to compare the tracer accumulation in the newly cultured My1/De tumor cell line (blasts) with that in healthy control and My1/De bone marrow suspensions. Post transplantation of My1/De cells under the left renal capsule of Long-Evans rats, primary My1/De tumorigenesis, and metastatic propagation were investigated using [18F]F-FDG PET imaging, whole-body autoradiography and phosphorimage analyses. To assess the organ uptake profile of the tumor-carrying animals we accomplished ex vivo biodistribution studies. Results: The tracer accumulation in the My1/De culture cells exceeded that of both the tumorous and the healthy bone marrow suspensions (p<0.01). Based on in vivo imaging, the subrenally transplanted My1/De cells resulted in the development of leukemia in the abdominal organs, and metastasized to the mesenterial and thoracic parathymic lymph nodes (PTLNs). The lymphatic spread of metastasis was further confirmed by the significantly higher %ID/g values of the metastatic PTLNs (4.25?0.28) compared to the control (0.94?0.34). Cytochemical staining of the peripheral blood, autopsy findings, and wright-Giemsa-stained post-mortem histological sections proved the leukemic involvement of the assessed tissues/organs. Conclusion: The currently established My1/De model appears to be well-suited for further leukemia-related therapeutic and diagnostic investigations.

Actions (login required)

Edit Item